The coronavirus disease 2019 (COVID-19) pandemic disrupted many mental health services for children; a study on the long-term effects of COVID-19 will soon kick off; a $13-billion deal has been struck for UnitedHealth to buy Change Healthcare.
A 24% increase in mental health issues was seen from mid-March through mid-October among children admitted to emergency departments across the United States, reports Kaiser Health News. For preteens and adolescents, there was a 31% jump. Experts highlight that forced isolation and loneliness, brought on by remote learning and lack of socialization, may be to blame, with spikes also seen in cases of severe depression, especially among those with autism. And with many hospitals running at capacity, children are more often being forced to wait days for a bed compared with only hours before the pandemic.
More than 25 countries and the Alzheimer’s Association are collaborating with the World Health Organization (WHO) to investigate the long-term effects of coronavirus disease 2019 (COVID-19), according to the Alzheimer’s Association. Evaluations will be performed on 2 groups of patients: (1) confirmed cases with follow-up at 6, 9, and 18 months, and (2) participants of current international studies to enhance understanding of the “underlying biology that may contribute to Alzheimer’s and other dementia.” A more complete understanding of how COVID-19 affects the brain is sought, particularly its immune response.
In a deal that includes a $5-billion debt, for a total value of $13 billion, UnitedHealth Group Inc will purchase Change Healthcare Inc, details Bloomberg. Together, the companies hope the deal will improve health care outcomes and lower costs by simplifying services through new software, data analytics, and technology offerings, among others. Andrew Witty, president and CEO of Optum, UnitedHealth’s payer division, reports the deal will streamline 3 vital processes—clinical, administrative, and payment—to better serve patients.
A new study highlights significant disparity in reimbursement rates across states between hospitals and Medicare; the first patient to receive a genetically modified pig kidney has died; research examines outcomes of over 500 patients receiving medication abortion pills by mail.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Oncology Onward: A Conversation With Dr Debra Patt of Texas Oncology
August 1st 2023Debra Patt, MD, PhD, MBA, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for episode 2 of our newest podcast, "Oncology Onward: Conversations With Innovators and Changemakers in Cancer Care."
Listen
CMS' 340B Repayment Proposal May Harm Vulnerable Hospitals, Reward Those With Higher Revenues
April 26th 2024The 340B hospitals not receiving an offsetting lump-sum payment from CMS following 2018-2022 cuts later ruled unlawful are disproportionately rural, publicly owned, and nonacademic, according to a new study.
Read More